Your email has been successfully added to our mailing list.

×
0 0 -0.00361010830324902 -0.00361010830324902 0.036101083032491 0.0523465703971119 0.0505415162454874 0.0418953068592058
Stock impact report

BioXcel Therapeutics Expands Indication for Lead Neuroscience Asset, BXCL501, to Treat Symptoms Associated with Opioid Drug Withdrawal

BioXcel Therapeutics, Inc (BTAI)  More Company Research Source: GlobeNewswire
Last bioxcel therapeutics, inc earnings: 11/14 07:00 am Check Earnings Report
PDF Clinical benefit observed in 10 of 10 patients; Human proof-of-concept established   Clinical opioid withdrawal symptoms during an escalating infusion of Dex (10 subjects) vs. placebo (5 subjects). Once symptoms reduced by = 50% the infusion was stopped and symptoms measured 30 minutes later. For subjects who did not achieve a reduction, after 3 hours the infusion was stopped and symptoms measured 30 minutes later. Provides further evidence of BXCL501’s mechanism of action Expands clinical advisory board with four additional industry leaders to guide on global development and market expansion of BXCL501 NEW HAVEN, Conn., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), today announced proof-of-concept data from its Phase 1b study of intraven [Read more]
Impact snapshot Event time: BTAI
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
BTAI alerts
from News Quantified
Opt-in for
BTAI alerts

from News Quantified
Opt-in for
BTAI alerts

from News Quantified